Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1689657)

Published in Endocrinology on March 01, 1990

Authors

K Köves1, P E Gottschall, T Görcs, J G Scammell, A Arimura

Author Affiliations

1: U.S. Japan Biomedical Research Laboratories, Tulane University, Belle Chasse, Louisiana 70037.

Articles by these authors

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (2001) 7.35

Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun (1989) 3.03

Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun (1971) 2.67

Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science (1971) 2.43

International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30

Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun (1971) 2.29

Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology (2000) 2.08

Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science (1975) 2.00

Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92

High-grade intensification of the end-product of the diaminobenzidine reaction for peroxidase histochemistry. J Histochem Cytochem (1982) 1.67

Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab (1999) 1.58

Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus. Proc Natl Acad Sci U S A (1980) 1.54

Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun (1990) 1.52

The regional distribution of somatostatin in the rat brain. Endocrinology (1975) 1.48

Isolation and structure of somatostatin from porcine hypothalami. Biochemistry (1976) 1.46

Solid phase synthesis of growth hormone-release inhibiting factor. Biochem Biophys Res Commun (1973) 1.44

Hypothalamic regulatory hormones. Science (1973) 1.41

Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol (1974) 1.40

Hypothalamic neurohormones regulating anterior pituitary function. Recent Prog Horm Res (1968) 1.36

Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies. Fertil Steril (1971) 1.35

Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol Suppl (Copenh) (1975) 1.34

Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology (1987) 1.31

Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest (1978) 1.31

The hypothalamus and reproduction. Am J Obstet Gynecol (1972) 1.29

Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med (1975) 1.27

Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol (1998) 1.26

Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry (1999) 1.26

LH-RH agonists and antagonists. Int J Gynaecol Obstet (1980) 1.24

Radioimmunoassay of somatostatin. Metabolism (1978) 1.22

Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest (1977) 1.22

Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci U S A (1990) 1.20

Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods (1997) 1.19

Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels. DNA Cell Biol (2001) 1.19

Stimulation of release and synthesis of luteinizing hormone(LH) and follicle stimulating hormone(FSH) in tissue culture of rat pituitaries in response to natural and synthetic LH and FSH releasing hormone. Endocrinology (1972) 1.17

Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. Am J Physiol (1990) 1.16

Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience (1992) 1.14

Letter: Immunohistochemical localization of somatostatin in the rat pancreas. J Histochem Cytochem (1975) 1.12

Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun (1976) 1.12

Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. J Med Chem (2000) 1.12

Gonadotropin-releasing hormone (GnRH) neurons and pathways in the rat brain. Cell Tissue Res (1984) 1.11

Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel. Endocrinology (1974) 1.10

Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors. Science (1982) 1.08

Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology (1990) 1.07

Identification of an estrogen-inducible phosphatase (PP5) that converts MCF-7 human breast carcinoma cells into an estrogen-independent phenotype when expressed constitutively. J Biol Chem (2001) 1.05

Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally. J Med Chem (1971) 1.05

Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci (1998) 1.05

Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem (1994) 1.05

Effect of intraventricular injection of dopamine, noreprinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood. Endocrinology (1979) 1.05

Isolation of the luteinizing hormone and follicle-stimulating hormone-releasing hormone from porcine hypothalami. J Biol Chem (1971) 1.05

Immunohistochemical localization of somatostatin (growth hormone release-inhibiting factor) in the guinea pig brain. Brain Res (1974) 1.05

Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther (1993) 1.04

Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation (1995) 1.03

Evidence for peptide nature of LH and FSH-releasing hormones. Biochem Biophys Res Commun (1971) 1.03

Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides (2002) 1.03

Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience (2002) 1.02

Stimulation of gastrin and somatostatin secretion from the isolated rat stomach by bombesin. Am J Physiol (1981) 1.02

Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res (1996) 1.02

Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem (1996) 1.02

Production of antiserum to LH-releasing hormone (LH-RH) associated with gonadal atrophy in rabbits: development of radioimmunoassays for LH-RH. Endocrinology (1973) 1.01

Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke (2000) 1.01

Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res (1997) 1.00

Release of LH and FSH after administration of synthetic LH-releasing hormone. J Clin Endocrinol Metab (1972) 1.00

Postischemic spontaneous hyperthermia and its effects in middle cerebral artery occlusion in the rat. Exp Neurol (2000) 0.99

Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res (1994) 0.98

Blockade of release of growth hormone by brain norepinephrine depletors. Endocrinology (1967) 0.98

Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science (1980) 0.98

Electron microscopic immunohistochemical localization of growth hormone-release inhibiting hormone (somatostatin) in the rat median eminence. Am J Anat (1974) 0.98

Recent approaches to fertility control based on derivative of LH-RH. Vitam Horm (1980) 0.97

Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology (1991) 0.97

Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. Biochem Biophys Res Commun (1977) 0.96

The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. J Clin Invest (1977) 0.95

Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat (1991) 0.95

Anti-NADase values in rheumatic fever and valvular disease. Jpn Circ J (1984) 0.95

Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta (1992) 0.95

Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro. Endocrinology (1977) 0.95

Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun (1990) 0.95

An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs. Acta Endocrinol (Copenh) (1977) 0.94

Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood. Endocrinology (1981) 0.94

Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett (1990) 0.94

Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci Res (1997) 0.94

Decline of tuberoinfundibular dopaminergic function resulting from chronic hyperprolactinemia in rats. Endocrinology (1984) 0.93

Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. Endocrinology (1991) 0.92

Stimulation of ACTH release by human interleukin-1 beta, but not by interleukin-1 alpha, in conscious, freely-moving rats. Biochem Biophys Res Commun (1987) 0.92

Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinology (1988) 0.92

Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am J Physiol (1989) 0.92

In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin. Peptides (1982) 0.92

Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. Gastroenterology (1996) 0.92

Paracrine regulation of gastric acid secretion by fundic somatostatin. Am J Physiol (1987) 0.91

Studies on retarded growth of rats with hereditary hypothalamic diabetes insipidus. Neuroendocrinology (1968) 0.91

Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology (1991) 0.90

Hypoglycemia, stress and growth hormone release: blockade of growth hormone release by drugs acting on the central nervous system. Endocrinology (1967) 0.90

Effect of stress on circadian periodicity in serum LH and prolactin concentration. Endocrinology (1972) 0.90

Hormonal induction of secretory granules in a pituitary tumor cell line. Endocrinology (1986) 0.90

Dual inhibitory pathways link antral somatostatin and histamine secretion in human, dog, and rat stomach. Gastroenterology (1995) 0.90